Related Experiment Video
Updated: Oct 22, 2025

Cell Type-specific Gene Expression Profiling in the Mouse Liver
Published on: September 17, 2019
Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics
Xiao-Fei Peng1, Shi-Feng Huang2, Ling-Juan Chen3
1Department of General Surgery, Qingyuan People's Hospital, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan 511518, Guangdong Province, China.
Abstract:
Early onset and progression of liver diseases can be driven by aberrant transcriptional regulation. Different transcriptional regulation processes, such as RNA/DNA methylation, histone modification, and ncRNA-mediated targeting, can regulate biological processes in healthy cells, as well also under various pathological conditions, especially liver disease. Numerous studies over the past decades have demonstrated that liver disease has a strong epigenetic component. Therefore, the epigenetic basis of liver disease has challenged our knowledge of epigenetics, and epigenetics field has undergone an important transformation: from a biological phenomenon to an emerging focus of disease research. Furthermore, inhibitors of different epigenetic regulators, such as m6A-related factors, are being explored as potential candidates for preventing and treating liver diseases. In the present review, we summarize and discuss the current knowledge of five distinct but interconnected and interdependent epigenetic processes in the context of hepatic diseases: RNA methylation, DNA methylation, histone methylation, miRNAs, and lncRNAs. Finally, we discuss the potential therapeutic implications and future challenges and ongoing research in the field. Our review also provides a perspective for identifying therapeutic targets and new hepatic biomarkers of liver disease, bringing precision research and disease therapy to the modern era of epigenetics.
Insights
Epigenetic mechanisms like RNA methylation and histone modification are key drivers of liver disease. Targeting these epigenetic regulators offers promising therapeutic strategies for hepatic diseases.
Area of Science:
- Molecular Biology
- Epigenetics
- Hepatology
Background:
- Aberrant transcriptional regulation significantly impacts liver disease onset and progression.
- Epigenetics, encompassing RNA/DNA methylation, histone modification, and ncRNA targeting, plays a crucial role in both healthy and diseased liver cells.
- Liver disease research increasingly focuses on its strong epigenetic component, transforming epigenetics from a basic biological phenomenon to a disease research focus.
Purpose of the Study:
- To review and synthesize current knowledge on five key epigenetic processes in hepatic diseases: RNA methylation, DNA methylation, histone methylation, microRNAs (miRNAs), and long non-coding RNAs (lncRNAs).
- To discuss the therapeutic potential of targeting epigenetic regulators, such as m6A-related factors, for liver disease prevention and treatment.
- To provide a perspective on identifying novel hepatic biomarkers and therapeutic targets within the epigenetics field for precision medicine.
Main Methods:
- Literature review and synthesis of existing studies on epigenetic mechanisms in liver disease.
- Discussion of interconnectedness and interdependence of different epigenetic processes.
- Analysis of therapeutic implications and future research directions.
Main Results:
- Epigenetic processes are fundamental to liver biology and disease pathogenesis.
- Inhibitors of epigenetic regulators show potential as therapeutic agents for liver conditions.
- The review consolidates understanding of RNA methylation, DNA methylation, histone methylation, miRNAs, and lncRNAs in hepatic diseases.
Conclusions:
- Epigenetic dysregulation is a critical factor in liver disease.
- Targeting epigenetic mechanisms presents a promising avenue for novel therapeutic strategies and biomarker discovery in hepatology.
- This review highlights the transformative role of epigenetics in advancing precision research and treatment for liver diseases.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Cell Specific Gene Expression
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Epigenetic Regulation

